Leader In The 'Growing' Sleep-Disordered Breathing Market Might Be Worth An Investment
June 25, 2015 at 08:22 AM EDT
In a report published Thursday, Barclays analyst Matthew Taylor initiated coverage of ResMed Inc. (NYSE: RMD) with an Equal-Weight ...
